Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

After the initial infection, both HSV and VZV enter a latent state in nerve cells of the infected host. Periodically these viruses can reactivate to produce infection and disease. The researchers demonstrated that, in addition to preventing infection, the MAOI drug TCP also prevented HSV reactivation. Importantly, says Dr. Kristie, the study contributes to the understanding of the mechanisms used by these viruses to infect host cells and of their cycles of latency–reactivation.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address